title: Once and future epidemics: Zika virus emerging.
authors.affiliation: Gary J. Nabel is Chief Scientific Officer of Global Research & Development (R&D), Sanofi, 640 Memorial Drive, Cambridge, MA 02139, USA. E-mail: gary.nabel@sanofi.comElias A. Zerhouni is President of Global R&D, Sanofi, 75008 Paris, France.
authors.forename: Gary J
authors.initials: GJ
authors.lastname: Nabel
authors.affiliation: Gary J. Nabel is Chief Scientific Officer of Global Research & Development (R&D), Sanofi, 640 Memorial Drive, Cambridge, MA 02139, USA. E-mail: gary.nabel@sanofi.comElias A. Zerhouni is President of Global R&D, Sanofi, 75008 Paris, France.
authors.forename: Elias A
authors.initials: EA
authors.lastname: Zerhouni
mesh_terms: D002986:Clinical Trials as Topic; D004196:Disease Outbreaks; D058872:Epidemics; D006801:Humans; D007167:Immunotherapy; D038622:Internationality; D000071244:Zika Virus / Q000502:physiology*; D000071243:Zika Virus Infection / Q000453:epidemiology*